文献速递乳腺MR

乳腺癌新辅助治疗后腋窝淋巴结残留转移预测:基于乳腺MRI的栖息地影像组学分析

Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI.
PubMed 文献 · Acad Radiol · 2026-08-26

本研究基于治疗前乳腺DCE-MRI,对cN+乳腺癌患者肿瘤区域进行K-means聚类划分栖息地并提取影像组学特征,构建栖息地影像组学模型预测NAT后RALNM。在两个中心686例患者中,栖息地模型内部验证AUC 0.805、外部测试AUC 0.802,优于全肿瘤模型;联合临床病理因素后AUC分别提升至0.871和0.857。

要点

  • 治疗前DCE-MRI栖息地影像组学可预测cN+乳腺癌NAT后腋窝淋巴结残留转移。
  • 栖息地模型预测效能优于全肿瘤影像组学模型。
  • 联合临床病理因素可进一步提高预测准确性。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop and validate a habitat radiomics model based on pretreatment breast magnetic resonance imaging (MRI) in predicting residual axillary lymph node metastasis (RALNM) after neoadjuvant therapy (NAT) in patients with clinically node-positive (cN+) breast cancer.

MATERIALS AND METHODS: This retrospective study included patients with cN+ breast cancer who underwent NAT at two centers between March 2018 and December 2022. Tumor region on pretreatment dynamic contrast-enhanced (DCE) MRI was segmented into distinct habitats using K-means clustering, and radiomics features were extracted from each habitat to build a habitat radiomics model. The conventional radiomics model was developed for comparison. Furthermore, a combined model integrating clinicopathological features with habitat radiomics signature was built. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC).

RESULTS: Among 686 included women (mean age ± standard deviation, 49.38 ± 10.37 years), RALNM was present in 351 patients (51.17%) after NAT. The habitat radiomics model achieved AUCs of 0.805 (95% confidence interval [CI]: 0.739-0.872) in the internal validation set and 0.802 (95% CI: 0.734-0.869) in the external test set, significantly outperforming the whole-tumor radiomics model in all cohorts (all p < 0.05). Integration of habitat radiomics with independent clinicopathological predictors yielded a combined model with further improved AUCs of 0.871 (95% CI: 0.816-0.926) and 0.857 (95% CI: 0.800-0.915) in the validation and external test sets, respectively.

CONCLUSION: Habitat radiomics analysis of pretreatment breast DCE-MRI demonstrates promising performance for predicting RALNM after NAT. The combined model incorporating habitat radiomics and clinicopathological factors further improves predictive accuracy.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Dai Y, Xu R, et al. Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI. Acad Radiol. 2026. PMID: 42648920. doi:10.1016/j.acra.2026.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。